Development of a gut microbiota model for the analysis of bacterial modifications of xenobiotics
Applied Microbiology and Biotechnology · 2026
DOI: 10.1007/s00253-026-13861-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Microbiology and Biotechnology, 2026. Verfasst von Natalie Hager und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Microbiology and Biotechnology, University of Bonn, Meckenheimer Allee 168, 53115, Bonn, Germany. Hauptthemen laut MEDLINE: Xenobiotics, Gastrointestinal Microbiome, Bacteria. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Food Safety Authority, Rheinische Friedrich-Wilhelms-Universität Bonn.
Abstract (Originalsprache)
The human gut microbiota influences host physiology by metabolizing xenobiotics, such as drugs, dietary additives, and environmental contaminants. To enable standardized assessment of microbial xenobiotic metabolism, we established a defined bacterial colon model from pooled human fecal samples, by preparing clean bacterial cell suspensions using density gradient centrifugation. The bacterial cell fraction remained structurally intact, allowing long-term preservation at −70 °C with glycerol as a cryoprotectant. The bacteria were fully reactivated without compromising cellular integrity. Glycerol as a disturbing substrate was removed by washing steps. The system preserved microbial diversity, enzymatic activity, and metabolic functionality over 24 h under anaerobic conditions. Unlike fecal-based models, the model was free from non-cellular contaminants, which could cause unpredictable interactions between test compounds and reactive components within the fecal matrix. Enzymatic assays demonstrated hydrolytic, reductive, and proteolytic activities comparable to native feces. 16S rRNA gene sequencing confirmed taxonomic stability and compositional shifts in response to different substrates. A fiber-rich substrate proved to be optimal for maintaining the bacterial composition over 24 h. We further applied the model to investigate the microbial biotransformation of selected model xenobiotics using high-performance liquid chromatography and mass spectrometry, capturing substrate-specific conversion patterns and formation of expected primary products. A versatile addition of food ingredients, dietary supplements, pharmaceuticals, and environmental chemicals is possible to analyze their effects on the composition of the microbiota, its enzymatic activity, and the excretion of metabolites and end products. Together, this bacterial colon model provides a reproducible, high-throughput capable and ethically viable platform for pharmaco microbiomic studies and next-generation risk assessment. Key points A novel bacterial colon model preserves human gut microbial diversity and activity. Fiber-rich substrates restore enzymatic function and SCFA production. The model enables standardized screening of microbial xenobiotic metabolism.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Microbiology and Biotechnology, University of Bonn, Meckenheimer Allee 168, 53115, Bonn, Germany.
- Institute for Food Chemistry, University of Bonn, Friedrich-Hirzebruch-Allee 7, 53115, Bonn, Germany.
- Institute for Nutrition and Microbiota, University of Bonn, Katzenburgweg 7, 53115, Bonn, Germany.
- Institute for Human Genetics, NGS Core Facility, University Hospital Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.
- Methodology and Scientific Support Unit, European Food Safety Authority (EFSA), Via Carlo Magno 1A, 43126, Parma, Italy.
- Institute of Microbiology and Biotechnology, University of Bonn, Meckenheimer Allee 168, 53115, Bonn, Germany. udeppen@unibonn.de.
Förderung
- European Food Safety Authority
- Rheinische Friedrich-Wilhelms-Universität Bonn
Zitieren
APA
Hager, N., Weyers, J. L., Falk, L., Passon, M., Simon, M. C., Seel, W., Dorne, J. C. M., & Deppenmeier, U. (2026). Development of a gut microbiota model for the analysis of bacterial modifications of xenobiotics. Applied Microbiology and Biotechnology. https://doi.org/10.1007/s00253-026-13861-7
Vancouver
Hager N, Weyers JL, Falk L, Passon M, Simon MC, Seel W, et al. Development of a gut microbiota model for the analysis of bacterial modifications of xenobiotics. Applied Microbiology and Biotechnology. 2026. doi:10.1007/s00253-026-13861-7
BibTeX
@article{Hager2026,
author = {Hager, Natalie and Weyers, Jan-Lorenz and Falk, Laura and Passon, Maike and Simon, Marie-Christine and Seel, Waldemar and Dorne, Jean-Lou Christian Michel and Deppenmeier, Uwe},
title = {Development of a gut microbiota model for the analysis of bacterial modifications of xenobiotics},
journal = {Applied Microbiology and Biotechnology},
year = {2026},
doi = {10.1007/s00253-026-13861-7}
}
EUVIMED